Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Penta Investments is a leading Central European investment group that has established a significant presence in the healthcare and life sciences sectors. The company operates two major healthcare pillars: Dr. Max, one of the largest pharmacy chains in Central and Eastern Europe, and Penta Hospitals International, a major provider of hospital and outpatient care across the region. While originally founded as a securities trading firm, Penta has evolved into a long-term strategic investor in healthcare infrastructure, retail pharmacy, and medical services. The group focuses on consolidating and modernizing healthcare delivery systems in markets such as the Czech Republic, Slovakia, and Poland.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Penta Financial Services.